Quoin pharmaceuticals signs exclusive licensing and distribution agreement with aft pharmaceuticals for its lead asset, qrx003

Aft gains exclusive rights to commercialize qrx003 in australia and new zealand

QNRX Ratings Summary

QNRX Quant Ranking